Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2012

14 Dec 2012
Biotron completes clinical stage of HIV clinical trial
28 Nov 2012
Results of Annual General Meeting
28 Nov 2012
Presentation to Annual General Meeting
27 Nov 2012
Commencement of three-month toxicology studies for BIT225
9 Nov 2012
Key Phase 2 HIV/HCV trial commenced
26 Oct 2012
Presentation to investors
25 Oct 2012
Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting
23 Oct 2012
Quarterly Report 30 September 2012
16 Oct 2012
Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference
11 Oct 2012
October 2012 edition of BITNews
12 Sep 2012
Change of Director’s Interest Notice
10 Sep 2012
Change of Director’s Interest Notice
31 Aug 2012
Year End Accounts and Preliminary Final Report for year ended 30 June 2012
27 Jul 2012
Quarterly Report 30 June 2012
8 May 2012
May 2012 edition of BITNews
20 Apr 2012
Quarterly Report 31 March 2012
3 Apr 2012
Exercise of options
7 Mar 2012
Appointment of Directors
28 Feb 2012
Half-year report 31 December 2011
15 Feb 2012
CEO Presentation at International Investor Conference
24 Jan 2012
Quarterly Report 31 December 2011
16 Jan 2012
Response to ASX price query
12 Jan 2012
CEO presentation at Biotech Showcase San Francisco
6 Jan 2012
Exercise of options raises $8.0 million

<<
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 30 May 2022 Legal Notices and Privacy